Peptide Dosage Charts
Quick-reference dosage tables for every major peptide therapy — reconstitution math, titration schedules, use-case dosing, and stack protocols. Each chart is reviewed against published literature, FDA labels where applicable, and notes whether a protocol is FDA-approved or research/clinical-practice extrapolated.
Educational tool — not medical advice. This calculator provides estimates based on population averages and published trial data. Outputs are not clinical recommendations and do not replace evaluation by a qualified prescriber. Do not start, stop, or change a peptide therapy based on the result of this tool.
Stack Protocols
Wolverine Stack
BPC-157 + TB-500 loading and maintenance phases, week by week, with injection-site notes and the evidence framing this stack actually deserves.
CJC-1295 + Ipamorelin
Pre-bed combined protocol (100 mcg of each), cycle length, and the 1×/day vs 3×/day question — the dominant GH-secretagogue stack in 2026 peptide therapy.
Browse by Therapy
All Dosage Charts
Healing & Recovery
BPC-157
Quick-reference protocols for tendon, gut, post-surgical, and systemic use, plus reconstitution math for the 5 mg and 10 mg vials.
TB-500
Loading and maintenance protocols, weekly schedule, and reconstitution math for the 5 mg vial — plus how TB-500 fits the Wolverine Stack.
GHK-Cu
Topical, subcutaneous, and oral protocols for the copper peptide GHK-Cu, with reconstitution math for the 50 mg and 100 mg vials.
KPV
Oral and subcutaneous protocols for KPV, the C-terminal tripeptide of α-MSH, with stacking notes for gut and inflammatory uses.
Weight Loss & Metabolic
Semaglutide
FDAThe FDA-labeled titration schedule for semaglutide (Wegovy and Ozempic), week by week, with the rationale for each step.
Tirzepatide
FDAThe FDA-labeled titration ladder from 2.5 mg to 15 mg, week by week, with the maintenance dose patients land on at each tier.
Retatrutide
Phase 2 trial titration schedule (1, 4, 8, 12 mg) and what compounded retatrutide protocols typically follow.
AOD-9604
Daily subcutaneous protocol, fasted-morning timing, and reconstitution math — with clear limits on the cited mouse evidence.
Tesamorelin
FDAFDA-labeled daily protocols for HIV-associated lipodystrophy — 1.4 mg for Egrifta SV, 1.28 mg for Egrifta WR — plus the off-label visceral fat reduction schedules.
MOTS-c
Practitioner protocols for the mitochondrial-derived peptide MOTS-c, with the caveat that human safety and efficacy data are very early.
Growth Hormone & Anti-Aging
Ipamorelin
Solo and combined-with-CJC-1295 protocols, reconstitution math, and the timing windows that align with natural GH pulses.
CJC-1295
Separates with-DAC human evidence from no-DAC clinic protocols, including common ipamorelin pairing and reconstitution math.
Sermorelin
Adult clinic-convention pre-bed protocol, 5-day-per-week schedule, and reconstitution math for the 5 mg vial.
Hexarelin
Clinic-convention short-cycle protocol, with cortisol and prolactin caveats that distinguish hexarelin from ipamorelin.
IGF-1 LR3
High-riskPractitioner protocols paired with the safety context this peptide actually deserves — hypoglycemia, cancer mitogenicity, and WADA-banned status.
Epithalon
Pulsed-course protocols (10–20 days, repeated twice yearly), reconstitution math, and the limits of the available evidence.
Thymosin Alpha-1
The internationally-labeled 1.6 mg twice-weekly protocol and off-label immune support cycles.
Cognitive & Nootropic
Selank
Clinic/vendor intranasal protocol and source limits for the Russian-approved anxiolytic peptide.
Semax
Clinic/vendor intranasal protocol and source limits for the Russian-approved cognitive and neuroprotective peptide.
DSIP
Pre-bed subcutaneous protocol, short PRN cycles, and the inconsistent efficacy literature you should know about.
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.